Cite
HARVARD Citation
Brose, M. et al. (n.d.). Vemurafenib for BRAFV600E-positive metastatic papillary thyroid cancer – Authors' response. Lancet oncology. 17 (11), pp. e469-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Brose, M. et al. (n.d.). Vemurafenib for BRAFV600E-positive metastatic papillary thyroid cancer – Authors' response. Lancet oncology. 17 (11), pp. e469-. [Online].